Trial Profile
A clinical study of Apatinib combined chemotherapy in the treatment of advanced gastric cancer with malignant peritoneal effusion
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 28 Apr 2016 New trial record